Report Content
Chapter 1 Methodology & Scope
1.1 Market scope & definitions
1.2 Research design
1.2.1 Research approach
1.2.2 Data collection methods
1.3 Base estimates & calculations
1.3.1 Base year calculation
1.3.2 Key trends for market estimation
1.4 Forecast model
1.5 Primary research and validation
1.5.1 Primary sources
1.5.2 Data mining sources
Chapter 2 Executive Summary
2.1 Industry 3600 synopsis
Chapter 3 Industry Insights
3.1 Industry ecosystem analysis
3.2 Industry impact forces
3.2.1 Growth drivers
3.2.1.1 Increasing prevalence of tinea pedis
3.2.1.2 Availability of effective OTC drugs
3.2.1.3 Growing awareness about tinea pedis and its symptoms
3.2.2 Industry pitfalls & challenges
3.2.2.1 Increased resistance to antifungal medications
3.2.2.2 Availability of alternative treatment options
3.3 Growth potential analysis
3.4 Regulatory landscape
3.5 Porter's analysis
3.6 PESTEL analysis
Chapter 4 Competitive Landscape, 2023
4.1 Introduction
4.2 Company matrix analysis
4.3 Competitive analysis of major market players
4.4 Competitive positioning matrix
4.5 Strategy dashboard
Chapter 5 Market Estimates and Forecast, By Drug Class, 2021 – 2032 ($ Mn)
5.1 Key trends
5.2 Antifungals
5.3 Combination drugs
Chapter 6 Market Estimates and Forecast, By Disease Type, 2021 – 2032 ($ Mn)
6.1 Key trends
6.2 Interdigital tinea pedis
6.3 Plantar tinea pedis
6.4 Vesicular tinea pedis
6.5 Acute ulcerative tinea pedis
Chapter 7 Market Estimates and Forecast, By Route of Administration, 2021 – 2032 ($ Mn)
7.1 Key trends
7.1.1 Topical
7.1.2 Cream
7.1.3 Gel
7.1.4 Lotion
7.1.5 Powder
7.1.6 Spray
7.1.2 Oral
Chapter 8 Market Estimates and Forecast, By Type 2021 – 2032 ($ Mn)
8.1 Key trends
8.2 OTC drugs
8.3 Prescription drugs
Chapter 9 Market Estimates and Forecast, By Age Group, 2021 – 2032 ($ Mn)
9.1 Key trends
9.2 Below 18 years
9.3 19 - 35 years
9.4 36 - 50 years
9.5 51 years and above
Chapter 10 Market Estimates and Forecast, By Distribution Channel, 2021 – 2032 ($ Mn)
10.1 Key trends
10.2 Hospital pharmacies
10.3 Retail pharmacies
10.4 Online pharmacies
Chapter 11 Market Estimates and Forecast, By Region, 2021 – 2032 ($ Mn)
11.1 Key trends
11.2 North America
11.2.1 U.S.
11.2.2 Canada
11.3 Europe
11.3.1 Germany
11.3.2 UK
11.3.3 France
11.3.4 Spain
11.3.5 Italy
11.3.6 Netherlands
11.3.7 Rest of Europe
11.4 Asia Pacific
11.4.1 China
11.4.2 Japan
11.4.3 India
11.4.4 Australia
11.4.5 South Korea
11.4.6 Rest of Asia Pacific
11.5 Latin America
11.5.1 Brazil
11.5.2 Mexico
11.5.3 Rest of Latin America
11.6 Middle East and Africa
11.6.1 South Africa
11.6.2 Saudi Arabia
11.6.3 UAE
11.6.4 Rest of Middle East and Africa
Chapter 12 Company Profiles
12.1 Bausch Health Companies Inc.
12.2 Bayer AG
12.3 GlaxoSmithKline plc
12.4 Glenmark Pharmaceuticals Limited
12.5 Pfizer, Inc.
12.6 Sebela Pharmaceuticals Holdings Inc.
12.7 Smith & Nephew plc
12.8 Sun Pharmaceutical Industries Ltd
12.9 Teva Pharmaceutical Industries Limited
12.10 Viatris Inc.
